Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LRAT | O95237 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27055134 | 0.86 | L3MBTL1 (0.39) | L3MBTL1MAPTAMY1ATSHR | |
| SCHEMBL19860207 | 0.85 | L3MBTL1 (0.36) | L3MBTL1MAPTMEN1LRATTRPV1 | |
| SCHEMBL17811737 | 0.85 | AMY1A (0.41) | L3MBTL1MAPTAMY1A | |
| SCHEMBL13563731 | 0.83 | — | — | |
| SCHEMBL19902013 | 0.81 | OGA (0.39) | AMY1AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL21122324 | 0.81 | OGA (0.39) | AMY1AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL21530603 | 0.81 | OGA (0.39) | AMY1AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL11915783 | 0.81 | OGA (0.39) | AMY1AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL13563735 | 0.81 | OGA (0.39) | AMY1AMEN1LRATTRPV1HSD17B10 | |
| SCHEMBL19326923 | 0.81 | MEN1 (0.33) | AMY1AMEN1LRATTRPV1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180110866-A1 | POLYMERIC ANTIBIOTICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-04-26 | — | — | US | disclosed |
| US-9889204-B2 | Polymeric antibiotics | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180110866-A1 | POLYMERIC ANTIBIOTICS | ALG1, TLR3, PGLS | L3MBTL1 2512/4885MAPT 3929/4885AMY1A 3064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.